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of these, administration of exogenous leptin improves
glucose tolerance and insulin sensitivity independently of
effects on food intake, probably by affecting neuroen-
docrine pathways that modulate insulin action in liver and
muscle (Halaas et al., 1995; Shimomura et al., 1999), as
this cytokine might also have direct effects on hepatic
cells (Lee et al., 2001). Furthermore, recent evidence indi-
cates that leptin treatment in insulin-deficient diabetic
rats restores normoglycemia (Chinookoswong et al.,
1999), and transgenic mice overexpressing leptin show
increased insulin sensitivity (Ogawa et al., 1999). Taken
together, these observations suggest a potent antidia-
betogenic effect of leptin in vivo.
Direct cross-talk between the leptin and insulin signal-
ing systems remains unclear. Some data suggest that
leptin can impair the early steps of insulin signaling in-
cluding tyrosine phosphorylation of IRS-1 in hepatocytes
(Cohen et al., 1996). Other studies demonstrate that lep-
tin can mimic effects of insulin, such as stimulation of
glucose transport and glycogen synthesis in C2C12 my-
otubes, and that these effects may be mediated by stim-
ulation of PI 3-kinase (Berti et al., 1997; Kellerer et al.,
1997). In isolated muscle or adipocytes, short-term incu-
bation with leptin does not stimulate glucose transport or
lipogenesis (Ranganathan et al., 1998; Zierath et al.,
1998).
Leptin exerts its effects through specific receptors of
which five isoforms have been described, generated by
alternative splicing of the primary transcript (Lee et al.,
1996). The leptin receptor is a member of the cytokine I
receptor family, of which gp 130 is a prototype. This class
of receptors stimulates gene transcription via activation
of cytosolic STAT proteins (Darnell, 1996, 1997). The long
form of the leptin receptor (OBRb) has the capacity to ac-
tivate the JAK/STAT (Baumann et al., 1996; Ghilardi et al.,
1996; Vaisse et al., 1996; Ghilardi and Skoda, 1997;
Tartaglia, 1997; White et al., 1997) and MAPK (Bjorbaek
et al., 1997) pathways, stimulate tyrosine phosphoryla-
tion of IRS-1 (Bjorbaek et al., 1997), and increase tran-
scription of fos, jun (Bjorbaek et al., 1997; Murakami
et al., 1997). OBRb is highly expressed in the hypothala-
mus, the primary site where leptin is thought to act
(Tartaglia et al., 1995). Leptin has been shown to activate
STAT3 in the hypothalamus via JAK2 (Carvalheira et al.,
2001). Tyrosine-phosphorylated STAT is translocated to
the nucleus where it is thought to bind to specific DNA
sequences and activate genes important for energy
homeostasis. Leptin may also exert direct effects at the
level of gene expression or cellular function on nonhypo-
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Chronic leptin treatment markedly enhances the ef-
fect of insulin on hepatic glucose production unpro-
portionally with respect to body weight loss and in-
creased insulin sensitivity. In the present study the
cross-talk between insulin and leptin was evaluated
in rat liver. Upon stimulation of JAK2 tyrosine phos-
phorylation, leptin induced JAK2 co-immunoprecipi-
tation with STAT3, STAT5b, IRS-1 and IRS-2. This
phenomenon parallels the leptin-induced tyrosine
phosphorylation of STAT3, STAT5b, IRS-1 and IRS-2.
Acutely injected insulin stimulated a mild increase in
tyrosine phosphorylation of JAK2, STAT3 and
STAT5b. Leptin was less effective than insulin in
stimulating IRS phosphorylation and their associa-
tion with PI 3-kinase. Simultaneous treatment with
both hormones yielded no change in maximal phos-
phorylation of STAT3, IRS-1, IRS-2 and Akt, but led to
a marked increase in tyrosine phosphorylation of
JAK2 and STAT5b when compared with isolated ad-
ministration of insulin or leptin. This indicates that
there is a positive cross-talk between insulin and
leptin signaling pathways at the level of JAK2 and
STAT5b in rat liver.
Key words: DNA-binding proteins /Drug effects / Insulin
physiology /Leptin pharmacology /Liver /Metabolism/
Protein-tyrosine kinase /Signal transduction.
Introduction
Leptin, the protein encoded by the ob gene, is a hormone
that is produced by adipocytes and acts through distinct
receptors in target organs to control food intake and en-
ergy metabolism (Tartaglia et al., 1995; Zhang et al.,
1994). Insulin resistance characterizes states of severe
leptin deficiency or resistance, like in ob/ob or db/db
mice, or genetic models of lipoatrophic diabetes. In some
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thalamic target tissues including hematopoietic cells, T
cells, the endocrine pancreas, the pituitary, the ovary,
adipocytes, skeletal muscle, and hepatocytes either
through the short or long forms of the receptor (Bennett
et al., 1996; Emilsson et al., 1997; Shimabukuro et al.,
1997; Siegrist-Kaiser et al., 1997; Yu et al., 1997; Cusin
et al., 1998; Liu et al., 1998; Lord et al., 1998;).
It is not yet completely clear whether, and by what
mechanisms, parts of the important metabolic effects of
leptin could be exerted directly at the level of peripheral
tissues, as opposed to indirect action through the central
nervous system. In the present study we have character-
ized leptin signal transduction in liver and determined
whether insulin and leptin share common intracellular
signal transduction pathways.
Results
In vivo Effect of Leptin on Tyrosine Phosphorylation
in the JAK/STAT Pathway in Liver
To determine leptin-induced tyrosine phosphorylation of
JAK2 we performed immunoprecipitation and Western
blotting of liver extracts with anti-JAK2 and anti-phos-
photyrosine antibodies, respectively. The time course ex-
periments were performed injecting 10– 6 M of leptin
through the portal vein of rats and collecting liver speci-
mens at different time points. As shown in Figure 1, JAK2
is strongly phosphorylated after 30 seconds of leptin
treatment, with maximal phosphorylation occurring at
90 seconds and decaying after 3 minutes (Figure 1A).
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Fig. 1 Effect of Leptin on JAK2, STAT3 and STAT5b Tyrosine Phosphorylation and STAT3/5b Association with JAK2 in the Liver in vivo.
(A) Liver extracts from animals treated with leptin for the time points indicated were prepared as described in Materials and Methods.
Proteins were immunoprecipitated from the extracts with anti-JAK2 antibody (IP, immunoprecipitation) and immunoblotted with anti-
phosphotyrosine antibody (P-Tyr). Stripped membranes were reblotted with anti-JAK2 antibody (n = 6). (B) Leptin-stimulated tyrosine
phosphorylation of STAT3. Tissue extracts from rats treated with leptin for the time points indicated were immunoprecipitated with anti-
STAT3 and blotted with anti-phospho-specific STAT3 (P-Tyr-STAT3). The same membranes used for STAT3 tyrosine phosphorylation
were stripped and reblotted with anti-JAK2 and anti-STAT3 antibodies (n = 6). (C) Leptin-stimulated tyrosine phosphorylation of STAT5b.
Tissue extracts from rats treated with leptin for the time points indicated were immunoprecipitated with anti-STAT5b and blotted with
anti-phosphotyrosine antibody. The same membranes used for STAT5 b tyrosine phosphorylation were stripped and reblotted with anti-
JAK2 and anti-STAT5b antibodies (n = 6). (D) Liver extracts from lean (L) and fat (F) rats treated with leptin for 90 seconds were prepared
as described in Materials and Methods. Tissue extracts were immunoprecipitated with anti-STAT5b and immunoblotted with anti-phos-
photyrosine antibody. The bar diagram represents the quantitative tyrosine phosphorylation of STAT5b. Data (mean ± SEM, n = 4) are
expressed relative to control, assigning a value of 100% to the lean control before leptin stimulation. *p<0.01, leptin lean vs. leptin
obese.
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To assess the ability of leptin to activate tyrosine phos-
phorylation of STAT3 and STAT5b we determined the time
course for this activation. Initially, we measured leptin-in-
duced tyrosine phosphorylation of STAT3 by im-
munoblotting with specific phospho-STAT3 antibodies.
Figure 1B shows a moderate increase in leptin-stimulat-
ed STAT3 phosphorylation in rat liver which is maximal at
3 min. Co-immunoprecipitation between JAK2 and
STAT3 in liver was observed in a similar fashion of JAK2
tyrosine phosphorylation. Subsequently, we measured
leptin-induced tyrosine phosphorylation of STAT5b, by
immunoprecipitation experiments using specific STAT5b
antisera, and then the immunoprecipitates were im-
munoblotted with anti-phosphotyrosine antibody. There
was a time-dependent increase in STAT5b phosphoryla-
tion after leptin injection, which paralleled the increase of
JAK2 phosphorylation after leptin stimulation (Figure 1C).
Similar to STAT3, there was also co-immunoprecipitation
of STAT5b and JAK2 after leptin stimulation. As expect-
ed, there was no alteration in STAT5b protein expression
after leptin infusion.
Our results show a very rapid, and presumably direct
induction of STAT5b phosphorylation by leptin in liver. To
confirm these data we measured leptin-induced STAT5b
tyrosine phosphorylation in the liver of fa/fa rats, which
have a mutation that decreases the cell-surface expres-
sion and leptin affinity of the leptin receptor, as a negative
control (White et al., 1997; da Silva et al., 1998). In in vivo
experiments, there was an increase of 6.9-fold in leptin-
induced tyrosine phosphorylation of STAT5b in the liver of
lean rats (Figure 1D), compared with 2.4-fold increases in
the liver of obese rats (p<0.05), representing a decrease
of about 70% in STAT5b phosphorylation in obese rats.
Effects of Leptin on IRS-1 and IRS-2 Tyrosine
Phosphorylation, PI 3 Kinase Docking and Akt Serine
Phosphorylation in Rat Liver
IRS proteins represent an important multifunctional inter-
face between many receptors and intracellular pathways.
A possible pathway toward IRS proteins phosphorylation
is via JAK kinases (Berti et al., 1997; Bjorbaek et al., 1997;
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Fig. 2 Leptin-Stimulated Tyrosine Phosphorylation of IRS-1 and IRS-2 and Their Association with the p85 Subunit of PI 3-Kinase in
Liver in vivo.
(A) Liver extracts from animals treated with leptin for the time points indicated were prepared as described in Materials and Methods. Tis-
sue extracts were immunoprecipitated with anti-JAK2 antibody (IP, immunoprecipitation) and immunoblotted with anti-IRS-1 and anti
IRS-2. Stripped membranes were reblotted with anti-JAK2 antibody (n = 4). (B) Leptin-stimulated tyrosine phosphorylation of IRS-1. Tis-
sue extracts from rats treated with leptin for the time points indicated were immunoprecipitated with anti-IRS-1 and blotted with anti-
phosphotyrosine antibody (P-Tyr). The same membranes used for IRS-1 tyrosine phosphorylation were stripped and reblotted with anti-
PI 3-kinase and anti IRS-1 antibodies (n = 6). (C) Leptin-stimulated tyrosine phosphorylation of IRS-2. Tissue extracts from rats treated
with leptin for the time points indicated were immunoprecipitated with anti-IRS-2 and blotted with anti-phosphotyrosine antibody. The
same membranes used for IRS-2 tyrosine phosphorylation were stripped and reblotted with anti-PI 3-kinase and anti IRS-2 antibodies
(n = 6). (D) Leptin-stimulated serine phosphorylation of Akt. Liver extracts from rats that were stimulated with leptin for the time point in-
dicated were prepared and proteins were separated by SDS-PAGE on 12% gels and blotted with phosphoserine-specific Akt antibodies.
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Kellerer et al., 1997; Carvalheira et al., 2001). Since JAK2
is activated by leptin, we evaluated the ability of leptin to
stimulate JAK2/IRS-1 and JAK2/IRS-2 association. Co-
immunoprecipitation of JAK2 and IRS-1 or IRS-2 in liver
was detected. In immunoprecipitates of JAK2 that were
blotted with anti-IRS-1 or anti IRS-2 antibodies, there
was an evident association between these proteins after
leptin stimulation. These results demonstrate that JAK2
interacts with IRS-1 and IRS-2 by forming stable com-
plexes in rat liver (Figure 2A).
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Fig. 3 Effect of Insulin and Leptin on the JAK/STAT Pathway in Extracts of Livers from Rats Treated with Leptin, Insulin or a Combi-
nation of Both.
(A) Tissue extracts from rats treated with saline, leptin, insulin or both hormones were immunoprecipitated with anti-JAK2 and blotted
with anti-phosphotyrosine antibody. The bar diagram shows the quantitative phosphorylation of JAK2. Data (mean ± SEM, n = 6) are
expressed as relative to control, assigning a value of 100% to the control mean. (B) Tissue extracts from rats treated with saline, leptin,
insulin or both hormones were immunoprecipitated with anti-STAT3 and blotted with anti-JAK2 antibody. The bar diagram shows the
quantitative association of STAT3 with JAK2. Data (mean ± SEM, n = 6) are expressed as relative to control, assigning a value of 100%
to the control mean. (C) Tissue extracts from rats treated with saline, leptin, insulin or both hormones were immunoprecipitated (IP, im-
munoprecipitation) with anti-STAT3 antobodies and blotted with anti-phospho-specific STAT3 (P-Tyr-STAT3). The bar graph shows the
quantitative phosphorylation of STAT3. Data (mean ± SEM, n = 6) are expressed as relative to control, assigning a value of 100% to the
control mean. (D) Tissue extracts from rats treated with saline, leptin, insulin or both hormones were immunoprecipitated with anti-
STAT5b and blotted with anti-JAK2 antibody. The diagram shows the quantitative association of STAT5b with JAK2. Data (mean ± SEM,
n = 6) are expressed relative to control, assigning a value of 100% to the control mean. (E) Tissue extracts from rats treated with saline,
leptin, insulin or both hormones were immunoprecipitated with anti-STAT5b and blotted with anti-phosphotyrosine antibody (P-Tyr). The
diagram shows the quantitative phosphorylation of STAT5b. Data (mean ± SEM, n = 6) are expressed as relative to control, assigning a
value of 100% to the control mean. *p<0.05 vs. leptin-treated rats.
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Figure 2B shows a clear increase in leptin-stimulated
IRS-1 phosphorylation, which was maximal at 90 s and al-
most vanished completely after 3 minutes. To better define
the levels of IRS-2 phosphorylation, we performed Western
blot analysis of tyrosyl-phosphorylated proteins in anti-
IRS-2 immunoprecipitates before and after stimulation with
leptin. Figure 2C shows that there was a marked increase in
leptin-stimulated IRS-2 phosphorylation in rat liver, which
was maximal at 90 s followed by a striking decay.
Previous studies (Backer et al., 1992; Folli et al., 1992)
have suggested that there is a relatively stable, high affin-
ity interaction between IRS-1 or IRS-2 and the 85 kDa
subunit of the PI 3-kinase such that both proteins can be
co-precipitated by antibodies to either protein. Blots that
had been previously immunoprecipitated with antibodies
against IRS-1 or IRS-2 were subsequently incubated with
antibodies against the 85 kDa subunit of PI 3-kinase (Fig-
ure 2B and C). There was little PI 3-kinase immunoreac-
tivity in the basal state of control rats. After 30 s of stimu-
lation with leptin, there were significant increases in
IRS-1 or IRS-2/PI 3-kinase association, which slightly de-
creased thereafter and returned to basal levels after
3 minutes. These observations are consistent with the
formation of a stable association between IRS-1 or IRS-2
and PI 3-kinase after leptin stimulation. As expected,
there were no changes in IRS-1 and IRS-2 protein levels.
Using antibodies against serine-phosphorylated Akt,
the levels of Akt activation were examined in liver after
leptin stimulation. As shown in Figure 2D, Akt phosphory-
lation in liver was unaltered by leptin injection.
The Effect of Simultaneous Administration of Leptin
and Insulin on the JAK/STAT Pathway
First we measured tyrosine phosphorylation of JAK2 in the
liver from rats that were stimulated with insulin, leptin or
both hormones for 90 s. The phosphorylation of JAK2 in liv-
er was increased approximately 3.8-fold by insulin stimula-
tion and approx, 3.6-fold by leptin. Insulin and leptin to-
gether showed ~8.4-fold increase in JAK2 tyrosine
phosphorylation, representing increases of ~230% above
the effects of leptin alone (Figure 3A). In a second experi-
ment, we evaluated insulin- and/or leptin-stimulated
JAK2/STAT3 association and STAT3 tyrosine phosphoryla-
tion in the liver from rats that were stimulated with insulin,
leptin or both hormones for 3 min. Insulin-stimulated STAT3
association with JAK2 showed an increase of ~3.5-fold and
STAT3 phosphorylation 2.0-fold over the basal levels, while
leptin led to a ~6.2- and 3.3-fold increase in JAK2/STAT3
association and STAT3 tyrosine phosphorylation, respec-
tively. However, simultaneous stimulation did not induce
additive effects on JAK2/STAT3 association and STAT3 ty-
rosine phosphorylation (Figure 3B and C). Finally, we as-
sessed the association between JAK2 and STAT5b and
STAT5b tyrosine phosphorylation in the liver from rats that
were stimulated with insulin, leptin or both hormones for
3 minutes. Insulin led to a ~2.5 fold increase in
JAK2/STAT5b association and to a 4.6-fold in tyrosine
phosphorylation of STAT5b over the basal levels, whereas
leptin induced a ~4.6-fold increase in JAK2/STAT5b asso-
ciation and a 6.1-fold increase in STAT5b tyrosine phos-
phorylation. Insulin and leptin together showed a ~9.3-fold
increase in JAK2/STAT5b association and ~10-fold in-
crease in STAT5b tyrosine phosphorylation, representing
enhancements of ~200% and ~170%, respectively, above
the effects of leptin alone (Figure 3D and E).
The Effect of Simultaneous Administration of Leptin
and Insulin on the PI 3-Kinase/Akt Pathway
We next examined whether simultaneous stimulation
with leptin and insulin could affect the early steps of the
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Fig. 4 Effect of Insulin and Leptin on IRS-1, IRS-2 and Akt Phosphorylation in Extracts of Livers from Rats Treated with Leptin, Insulin
or a Combination of Both.
(A) Tissue extracts from rats treated with saline, leptin, insulin or both hormones were immunoprecipitated with anti-IRS-1 and blotted
with anti-phosphotyrosine antibody. The bar diagram shows the quantitative phosphorylation of IRS-1. Data (mean ± SEM, n = 6) are
expressed as relative to control, assigning a value of 100% to the control mean. (B) Tissue extracts from rats treated with saline, leptin,
insulin or both hormones were immunoprecipitated with anti-IRS-2 and blotted with anti-phosphotyrosine antibody. Shown is the quan-
titative phosphorylation of IRS-2. Data (mean ± SEM, n = 6) are expressed as relative to control, assigning a value of 100% to the con-
trol mean. (C) Western blots of liver extracts from rats treated with leptin for 5 minutes with phosphoserine-specific Akt antibodies. The
bar diagram shows the quantitative phosphorylation of Akt. Data (mean ± SEM, n = 6) are expressed as relative to control, assigning a
value of 100% to the control mean.
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insulin signal transduction pathways. We measured tyro-
sine phosphorylation of IRS proteins in the liver from rats
that were stimulated with insulin, leptin or both hormones
for 90 s. The phosphorylation of IRS-1 in liver showed an
approx. 9.0-fold increase with insulin stimulation and ap-
prox. 3.3-fold with leptin. The effect of insulin and leptin
was similar to insulin alone (Figure 4A). IRS-2 tyrosine
phosphorylation upon insulin and/or leptin stimulation
was comparable with that obtained in IRS-1 immunopre-
cipitates (Figure 4B). Akt serine phosphorylation was ex-
amined in the liver from rats that were stimulated with in-
sulin, leptin or both hormones for 5 min. Leptin alone had
no effect on Akt tyrosine phosphorylation in liver. Insulin
induced a ~4-fold increase in Akt phosphorylation and no
additive effect was observed by the addition of leptin
(Figure 4C).
Discussion
In the present study we have investigated the possibility
of direct interactions between insulin and leptin action in
liver, focusing on some key intermediate steps in these
signaling pathways. Our results show that leptin, upon
stimulation of JAK2 tyrosine phosphorylation, induced
JAK2 co-immunoprecipitation with STAT3, STAT5b, IRS-
1 and IRS-2. These phenomena paralleled the leptin-in-
duced tyrosine phosphorylation of STAT3, STAT5b, IRS-1
and IRS-2. Insulin stimulated a mild increase in tyrosine
phosphorylation of JAK2, STAT3 and STAT5b in liver.
Leptin was much less effective than insulin at stimulating
IRS/PI 3-kinase pathways. Akt phosphorylation was not
changed by leptin but increased by insulin. Whereas
there was no change in maximal phosphorylation of IRS-
1, IRS-2, Akt and STAT3, simultaneous stimulation with
both hormones resulted in a marked increase in tyrosine
phosphorylation of JAK2 and STAT5b when compared
with isolated administration of insulin or leptin. Thus,
there is direct cross-talk between the insulin and leptin
signaling pathways at the level of JAK2 and STAT5b, in a
way that the simultaneous administration of both hor-
mones modulates the signal that is transduced through
the common elements of these pathways.
The molecular mechanisms by which OBR couples to
tyrosine phosphorylation events in liver are not known. In
the present study the rapid tyrosine phosphorylation and
association of JAK2 with IRS-1, IRS-2, STAT3 and STAT-
5b proteins suggests that a large signaling complex is
formed with the OBR upon leptin treatment. Co-immuno-
precipitation of JAK2 and IRSs, STAT3 and -5b could be
due the direct association of JAK2, IRSs, STAT3 and
STAT5b with the OBR, or indirect association of IRSs,
STAT3 and -5b with the JAK2 kinase. There are several
mechanisms by which JAK2, IRSs and STATs may asso-
ciate with OBR. One possibility is that JAK2 initially asso-
ciates with the OBR and leads to recruitment of IRSs,
STAT3 and -5b proteins. A second is that OBR recruit
IRSs and/or STAT proteins, which serve as adapter mole-
cules for binding JAK2. A third possibility is that JAK2,
IRSs and STATs associate with the receptor, and upon lig-
and binding to the receptor, JAK2 phosphorylates the as-
sociated IRSs and STAT proteins. Further studies (muta-
tional analysis of the OBR and/or experiments in JAK2
deficient cell lines) will be required to assess this issue.
A previous in vivo study implicated only STAT3 in hy-
pothalamic leptin signaling, whereas experiments involv-
ing transfected cells provide evidence for the activation
of other STAT isoforms, depending on the cellular model
(Baumann et al., 1996; Ghilardi et al., 1996; Vaisse et al.,
1996; White et al., 1997). The nature of the STAT isoforms
required for transducing the leptin signal is still contro-
versial and may depend on the cellular context and the
concomitant presence of other stimuli in vivo. Here we
show that not only tyrosine phosphorylation of STAT3,
but also STAT5b, is markedly activated in hepatic tissue
by leptin administration. These results are in accordance
with a recent study showing that leptin administration i.v.
induces a STAT5b gel shift in nuclear extracts of hepato-
cytes (Briscoe et al., 2001). The current study is the first
demonstration of leptin-induced STAT5b activation in liv-
er in vivo.
Originally it was thought that the hypothalamus was
the only tissue expressing OBRb. However, recent evi-
dence at the level of messenger RNA expression and cel-
lular function suggest that peripheral organs including
adipose tissue also express OBRb (Cohen et al., 1996;
Emilsson et al., 1997; Siegrist-Kaiser et al., 1997; Yu
et al., 1997). Unlike OBRb, the short isoform of the leptin
receptor (OBRa) appears incapable of activating STATs,
although it can mediate tyrosine phosphorylation of JAK2
(Bjorbaek et al., 1997). Several studies have analyzed al-
teration in leptin signaling induced by the fa mutation in
OBR, demonstrating a defective activation of STAT5b by
the mutant receptor (White et al., 1997). Thus, our data
showing leptin-induced STAT5b phosphorylation in liver
of lean rats, but a mild STAT5b phosphorylation in liver of
Zucker fa/fa rats, support the notion that hepatocytes ex-
press OBRb as suggested previously (Kim et al., 2000).
Intracellular interactions between different signaling
systems may function as mechanisms for enhancing or
counter-regulating hormone action. In the case of insulin,
the cross-talk with leptin-mediated pathways results in
direct interactions between insulin and leptin signaling
systems at the level of JAK2 and STAT5b. Simultaneous
stimulation with both hormones led to increased tyrosine
phosphorylation of JAK2 and STAT5b and the associa-
tion of JAK2 with STAT5b. In contrast, no effect on STAT3
phosphorylation or JAK2/STAT3 association was ob-
served when compared with acute insulin or leptin ad-
ministration. These results suggest that the positive
cross-talk between insulin and leptin signaling is due to
additive effects on JAK2 activation and divergence of as-
sociation between JAK2 and STAT3 and -5b. Another
possible reason for this difference is differential
insulin/leptin signal amplification. STAT5b can be activat-
ed either by insulin through the insulin receptor in a JAK-
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independent fashion (Sawka-Verhelle et al., 1997, 2000)
or with OBRb by leptin (Briscoe et al., 2001). In contrast,
the role of insulin in the activation of the STAT3 is contro-
versial (Ceresa and Pessin, 1996; Kim et al., 2000;Carval-
heira et al., 2001) and may be tissue-specific. Here we
demonstarted a mild activation of STAT3, but this effect
was not additive with leptin.
Although leptin has an insulin-sensitizing effect, which
is evident from the rapid reduction of glucose and insulin
levels in leptin-deficient, insulin-resistant ob/ob mice af-
ter leptin administration (Pelleymounter et al., 1995) and
the enhanced insulin-stimulated glucose disposal in
normal rats infused with leptin (Sivitz et al., 1997), in
the present study we found that leptin and insulin elicit
overlapping but distinct signaling pathways toward the PI
3-kinase/AKT pathway. Notably, i.v. injection of leptin re-
sults in phosphorylation of JAK2 and a mild phosphoryla-
tion of IRS-1 and IRS-2 with a parallel increase in IRSs/PI
3-kinase association compared with the large effects of
insulin on these signaling steps. In liver, Akt shows en-
hanced serine phosphorylation after insulin, but not after
leptin stimulation.
The effect of leptin stimulation on IRS-1 and IRS-2 ty-
rosine phosphorylation and its effects on insulin-induced
signaling is dependent of the cell line used. Cohen et al.
(1996) reported that leptin caused attenuation of several
insulin-induced activities, including tyrosine phosphory-
lation of the IRS-1 on human hepatic cells. On the other
hand, Wang et al. (1997) showed that leptin treatment in-
crease IRS-1 and IRS-2 tyrosine phosphorylation on he-
patoma cells. Furthermore, Kellerer et al. (1997) demon-
strated that leptin has insulin-like effects on glucose
transport and glycogen synthesis in C2C12 myotubes and
that these effects are dependent on IRS-2 tyrosine phos-
phorylation. In accordance with Kim et al. (2000), here we
showed that in the liver the treatment with the combina-
tion of the two hormones is not additive, synergistic or in-
hibitory in the PI 3-Kinase-Akt pathway.
In conclusion, we have presented evidence for rapid,
direct effects of leptin administration in vivo on intracellu-
lar signaling pathways in the liver and we observed a con-
vergence of leptin and insulin signaling at the level of the
PI 3-Kinase-Akt pathway without synergism. Moreover,
our results indicate a direct and positive cross-talk be-
tween insulin and leptin at the level of JAK2 and STAT-5b
tyrosine phosphorylation and association. This mecha-
nism may serve to potentiate the activity of both insulin
and leptin pathways and to increase stimulation in physi-
ological processes such as the regulation of carbohy-
drate and lipid metabolism, which are under the com-
bined control of insulin and leptin.
Materials and Methods
Materials
The reagents for SDS-PAGE and immunoblotting were obtained
from Bio-Rad (Richmond, USA). Tris base, phenylmethylsulfonyl
fluoride, aprotinin, dithiothreitol, Triton X-100, Tween-20, glyc-
erol, affinity-purified rabbit anti-mouse IgG and bovine serum al-
bumin (BSA, fraction V) were obtained from Sigma Chemical Co.
(St. Louis, USA). Leptin was acquired from Calbiochem (La Jol-
la, USA). Sodium amobarbital and human recombinant insulin
(Humulin R) were purchased from Eli Lilly & Co. (Indianapolis,
USA). Protein A-Sepharose 6Mb, [125I]protein A and nitrocellu-
lose paper (Hybond ECL, 0.45 µm) were obtained from Amer-
sham (Piscataway, USA). Antibodies to IRS-1 (SC-559), IRS-2
(SC-8299), JAK2 (SC-294G), STAT3 (SC-483), STAT5b (SC-835)
and phosphotyrosine (SC-508) were purchased from Santa Cruz
Biotechnology (Santa Cruz, USA). Antibodies against the
p85 subunit of PI 3-kinase (06 – 195) were from Upstate Biotech-
nology (Lake Placid, USA). Anti-Akt-Ser-473 (9271L) and anti-
STAT3 phosphotyrosine 705-specific antibodies (9131) were
from New England Biolabs (Beverly, USA).
Animals
Eight week-old male Wistar and Zucker rats were allowed ac-
cess standard rodent chow and water ad libitum. All experi-
ments involving animals were in accordance with the guidelines
of the Brazilian College for Animal Experimentation (COBEA).
Room temperature was maintained between 21 – 23°C, and a
12-hour light, 12-hour-dark cycle was used.
Surgical Procedures and Tissue Preparation
After 7 hours fast, rats were anesthetized with sodium amobar-
bital (15 mg/kg body weight, intraperitoneally), and submitted to
the surgical procedure as soon as the anesthesia was assured
by the loss of pedal and corneal reflexes. The abdominal cavity
was opened, the portal vein was exposed, and in vivo stimula-
tion of the liver was obtained by injection of 500 µl of normal
saline (0.9% NaCl), insulin (10– 6 M), leptin (10– 6 M) or an equimo-
lar mixture of insulin (10– 6 M) and leptin (10– 6 M) into the portal
vein. Fragments of the livers were excised in a time dependent
manner. The tissue was minced coarsely, and homogenized im-
mediately in extraction buffer [1% Triton X-100, and 100 mM Tris
(pH 7.4) containing 100 mM sodium pyrophosphate, 100 mM
sodium fluoride, 10 mM EDTA, 10 mM sodium vanadate, 2 mM
phenylmethylsulfonyl fluoride, and 0.1 mg aprotinin/ml] at 4°C
with a Polytron PTA 20S generator (model PT 10/35, Brinkmann
Instruments, Inc., Westbury, USA) operated at maximum speed
for 30 s. The extracts were centrifuged at 30 000 g and 4°C in a
Beckman 70.1 Ti rotor (Palo Alto, USA) for 20 min to remove in-
soluble material, and the supernatant of these tissues was used
for immunoprecipitation with the indicated antibodies.
Protein Analysis by Immunoblotting
The precipitated proteins were treated with Laemmli sample
buffer (Laemmli, 1970) containing 100 mM dithiothreitol and
heated in a boiling water bath for 4 min, after which they were
subjected to SDS-PAGE in a Bio-Rad miniature slab gel appa-
ratus (Mini-Protean, Bio-Rad Laboratories, Inc., Richmond,
USA). Electrotransfer of proteins from the gel to nitrocellulose
was performed for 90 min at 120 V (constant) in a Bio-Rad
miniature transfer apparatus (Mini-Protean) as described (Tow-
bin et al., 1979) except for the addition of 0.02% SDS to the
transfer buffer to enhance the elution of high molecular mass
proteins. Nonspecific protein binding to the nitrocellulose was
reduced by preincubating the filter for 2 h at room temperature
at 4°C in blocking buffer (5% nonfat dry milk, 10 mM Tris,
150 mM NaCl, and 0.02% Tween-20). The nitrocellulose blot
was incubated with the indicated antibodies, diluted in blocking
buffer (0.3% BSA instead of nonfat dry milk) overnight at 4°C,
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and then washed for 20 min with blocking buffer without milk.
An amplification step with rabbit anti-mouse IgG (1:1000 final
dilution) was added to the standard protocol when monoclonal
anti-phosphotyrosine antibodies were employed in Western
blotting experiments. The blots were subsequently incubated
with 2 mCi [125I]protein A (30 mCi/mg) in 10 ml blocking buffer
for 2 h at room temperature and then washed again for 20 min
as described above. [125I]Protein A bound to the antipeptide an-
tibodies was detected by autoradiography using preflashed
Kodak XAR film (Eastman Kodak Co., Rochester, USA) with
Cronex Lightning Plus intensifying screens at – 80°C for
12 – 48 h. Band intensities were quantified by optical densitom-
etry (Scion Image software) of the developed autoradiographs.
To exclude unspecific interactions between the investigated
proteins and protein-A Sepharose control precipitations without
the specific antibodies were performed, followed by im-
munoblotting with anti-JAK2, anti IRS-1, anti-IRS-2, anti-STAT3
and anti-STAT5b antibodies, and no band was detected. The
results indicated that the immunoprecipitation performed in the
experiments described here do not allow the detection of un-
specific interactions.
Statistical Analysis
Where appropriate, the results were expressed as the mean ±
SEM accompanied by the indicated number of experiments.
Kruskal-Wallis 1-way ANOVA test was used in the statistical
comparisons with p<0.05 indicating significance.
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